Viatris’ Mylan and Hetero Drugs are to supply dolutegravir-based treatment regimens for HIV in Azerbaijan, Belarus, Kazakhstan and Malaysia after agreeing to partner with the Medicines Patent Pool.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?